Johnson and Johnson to split into 2 companies Medical Dialogues Team13 Nov 2021 5:01 PM ISTNew Delhi: US pharma giant Johnson and Johnson (JnJ) has recently announced that it is splitting into two companies, separating the division that...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Pharma firms seek Govt nod to hike drug prices by 20 percent: Report Medical Dialogues Team11 Nov 2021 4:50 PM ISTNew Delhi: In view of the unprecedented crisis faced by Indian pharmaceutical firms due to the tremendous escalation of input costs, a lobby group...
CDSCO raises cybersecurity alert on Medtronic remote controllers used in insulin pumps Medical Dialogues Team10 Nov 2021 2:07 PM ISTNew Delhi: Citing potential cybersecurity risks, the Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for...
CDSCO extends date of getting license for medical devices to June 30, 2022, Details Medical Dialogues Team9 Nov 2021 6:00 PM ISTNew Delhi: In relief to manufacturers and importers of medical devices, the Central Drug Standard Control Organisation (CDSCO) has extended the date...
Firm that managed Pfizer COVID vaccine trial sites falsified data, claims BMJ Medical Dialogues Team8 Nov 2021 6:27 PM ISTNew Delhi: In a shocking revelation, a whistleblower has accused Ventavia, a Pfizer Covid-19 vaccine phase 3 clinical trial subcontractor, of...
Torrent Pharma gets CDSCO panel nod to manufacture, market Pregabalin, Duloxetine FDC Medical Dialogues Team7 Nov 2021 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Proud Moment for India: Bharat Biotech Covaxin gets WHO approval for emergency use listing Farhat Nasim6 Nov 2021 3:09 PM ISTBesides demonstrating 77.8 per cent effectiveness against symptomatic COVID, Covaxin has shown 65.2 per cent protection against the new Delta variant.
Pfizer secures CDSCO panel nod to study Hemophilia drug Marstacimab Medical Dialogues Team5 Nov 2021 6:13 PM ISTNew Delhi: In a significant development, drug firm Pfizer has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Glenmark gets CDSCO panel nod to import, market Akynzeo Medical Dialogues Team4 Nov 2021 11:30 AM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
CDSCO cautions employees against ransomware attack, sensitive data encryption Medical Dialogues Team3 Nov 2021 6:04 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has informed employees that the computer systems installed in CDSCO and the...
HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
